The U.S. Department of Education has found that Duke University's School of Medicine discriminated against white and Asian applicants in its admissions process, marking one of the most significant enforcement actions against a major medical school since the Supreme Court struck down race-conscious admissions in 2023.
The department's Office for Civil Rights concluded that Duke used race as a factor in admissions decisions for its medical school, violating Title VI of the Civil Rights Act of 1964, which bars racial discrimination in programs receiving federal funding. The finding, first reported by the Washington Free Beacon, puts billions of dollars in federal funding at risk if the university fails to comply with a resolution agreement.
The Office for Civil Rights opened its investigation after receiving a complaint alleging that Duke's medical school admissions process gave preferential treatment to applicants based on race. Investigators examined admissions data and practices at the School of Medicine and determined that the school had in fact used race as a factor when deciding which applicants to admit.
The finding directly implicates Duke in violating the Supreme Court's June 2023 ruling in Students for Fair Admissions v. Harvard, which held that race-conscious admissions programs at Harvard and the University of North Carolina were unconstitutional. That decision effectively banned the use of race as a factor in college admissions nationwide, overturning decades of precedent that had permitted limited consideration of race under certain conditions.
Duke's medical school is among the most prestigious in the country and receives substantial federal funding through research grants and student financial aid programs. Title VI applies to any institution that receives federal dollars, giving the Department of Education broad authority to investigate and sanction schools that engage in racial discrimination.
Rather than face a potential cutoff of federal funding, Duke entered into a resolution agreement with the Office for Civil Rights. Under the terms of the agreement, the university must take steps to bring its admissions practices into compliance with federal civil rights law.
The specifics of the resolution agreement require Duke to cease using race as a factor in medical school admissions. The university must also review and revise its admissions policies to ensure they comply with Title VI and the Supreme Court's ruling. The agreement includes monitoring provisions that will allow the Department of Education to verify Duke's compliance over time.
The stakes for Duke are enormous. The university receives billions of dollars in federal funding across its various schools, hospitals, and research programs. A finding of noncompliance, if Duke were to resist the resolution terms, could theoretically jeopardize that entire funding stream.
The Duke finding represents a concrete enforcement action in what has been a slow-developing compliance landscape since the Supreme Court's 2023 decision. While the ruling in Students for Fair Admissions was sweeping in its legal scope, critics on the right have argued that many universities have simply found workarounds or continued race-conscious practices under different labels.
The Department of Education under the current administration has signaled a willingness to aggressively enforce the SFFA decision. The Duke case sends a clear message that elite institutions are not exempt from scrutiny, even when they frame diversity initiatives in terms that avoid explicit racial preferences.
Medical school admissions have drawn particular attention in the post-SFFA era. Critics have pointed to persistent racial gaps in admissions outcomes at top medical schools as evidence that some institutions continue to weigh race, either directly or through proxy measures designed to achieve similar demographic results. Defenders of diversity efforts in medical education have argued that a diverse physician workforce is essential to addressing health disparities and serving underrepresented communities.
Duke University has agreed to the resolution terms, though the university's public posture on the matter reflects the difficult position elite institutions now occupy. By entering the agreement, Duke avoids a protracted legal battle and the immediate threat to its federal funding. But the finding itself carries reputational weight, particularly for a medical school that competes for top applicants and faculty against peer institutions.
Investigators have not publicly detailed the precise mechanisms Duke used to incorporate race into its admissions decisions, or for how long the practice continued after the Supreme Court's 2023 ruling. Those details may emerge as the resolution agreement's monitoring provisions take effect and the university submits compliance reports to the Office for Civil Rights.
The case also raises questions about how many other medical schools and graduate programs may be engaged in similar practices. The Office for Civil Rights has the authority to open investigations based on complaints or on its own initiative, and the Duke precedent could encourage additional complaints from applicants who believe they were disadvantaged by race-conscious admissions at other institutions.
The federal funding dimension of this case cannot be overstated. Duke University's research enterprise alone brings in hundreds of millions of dollars in federal grants annually, much of it flowing through the medical school and Duke University Health System. The threat of losing that funding gives the Department of Education extraordinary leverage in enforcement actions.
Title VI enforcement has historically been a slow and often toothless process, with the nuclear option of funding termination rarely invoked. But the current political environment has shifted the calculus. The administration has shown a willingness to use funding threats as a compliance tool across higher education, and the Duke case fits squarely within that approach.
For white and Asian applicants who may have been disadvantaged by Duke's admissions practices, the resolution agreement offers a measure of institutional accountability. But it does not provide individual remedies for applicants who were denied admission during the period when race was being used as a factor. Whether any affected applicants pursue private litigation remains an open question.
The Office for Civil Rights will monitor Duke's compliance with the resolution agreement going forward. The university must demonstrate that its revised admissions policies and practices no longer incorporate race as a factor in decision-making. Failure to comply could reopen the enforcement action and put federal funding directly at risk.
The case is likely to energize conservative legal organizations that have been pushing for aggressive enforcement of the SFFA ruling. Groups like Students for Fair Admissions, which brought the original Supreme Court case, have continued to file complaints and pursue litigation against universities they believe are defying the court's mandate.
The Duke finding also puts other elite medical schools on notice. Institutions that have maintained diversity-focused admissions practices in the wake of SFFA now face a concrete example of what federal enforcement looks like. The question is whether those schools will proactively revise their practices or wait for an investigation to force the issue.
The Supreme Court said the Constitution does not permit sorting applicants by skin color. The federal government just told one of America's top medical schools that the rule applies to them, too.
